IN2015DN03826A - - Google Patents
Info
- Publication number
- IN2015DN03826A IN2015DN03826A IN3826DEN2015A IN2015DN03826A IN 2015DN03826 A IN2015DN03826 A IN 2015DN03826A IN 3826DEN2015 A IN3826DEN2015 A IN 3826DEN2015A IN 2015DN03826 A IN2015DN03826 A IN 2015DN03826A
- Authority
- IN
- India
- Prior art keywords
- subject
- pharmaceutical composition
- concentration
- dose
- time point
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 239000000090 biomarker Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261717609P | 2012-10-23 | 2012-10-23 | |
| PCT/US2013/066238 WO2014066428A1 (en) | 2012-10-23 | 2013-10-22 | Drug monitoring and regulation systems and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN03826A true IN2015DN03826A (pm) | 2015-10-02 |
Family
ID=50486139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3826DEN2015 IN2015DN03826A (pm) | 2012-10-23 | 2013-10-22 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20140114676A1 (pm) |
| EP (1) | EP2911642B1 (pm) |
| KR (1) | KR20150079660A (pm) |
| CN (1) | CN104884029A (pm) |
| AU (2) | AU2013334700A1 (pm) |
| CA (1) | CA2887669A1 (pm) |
| HK (1) | HK1214498A1 (pm) |
| IN (1) | IN2015DN03826A (pm) |
| WO (1) | WO2014066428A1 (pm) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102223018B1 (ko) | 2012-10-05 | 2021-03-05 | 다이앤 몰드 | 수학적 모형 함수로서 환자-특이적 투여법을 제공하는 시스템 및 방법 |
| US10777313B2 (en) | 2013-06-13 | 2020-09-15 | Carefusion 303, Inc. | Analytics regarding ventilated patients |
| US11183287B2 (en) * | 2013-06-13 | 2021-11-23 | Carefusion 303, Inc. | Analytics regarding patient care |
| US12027243B2 (en) | 2017-02-17 | 2024-07-02 | Hc1 Insights, Inc. | System and method for determining healthcare relationships |
| US20210005324A1 (en) * | 2018-08-08 | 2021-01-07 | Hc1.Com Inc. | Methods and systems for a health monitoring command center and workforce advisor |
| WO2016115492A1 (en) * | 2015-01-16 | 2016-07-21 | Ameritox, Ltd. | Normalizing measured drug concentrations in oral fluids and testing for potential non-compliance with drug treatment regimen |
| CA2988724C (en) * | 2015-04-09 | 2023-10-10 | Diane R. Mould | Systems and methods for patient-specific dosing |
| MY197302A (en) * | 2016-04-15 | 2023-06-12 | Takeda Pharmaceuticals Co | Method and apparatus for providing a pharmacokinetic drug dosing regimen |
| US10896749B2 (en) * | 2017-01-27 | 2021-01-19 | Shire Human Genetic Therapies, Inc. | Drug monitoring tool |
| CN109718112B (zh) * | 2017-10-30 | 2020-12-29 | 京东方科技集团股份有限公司 | 用药提醒方法、装置及计算机可读存储介质 |
| CN112005304A (zh) * | 2018-03-20 | 2020-11-27 | 西托姆克斯治疗公司 | 用于哺乳动物受试者中的可活化抗体种类的定量药理学建模的系统和方法 |
| CN108334116A (zh) * | 2018-04-23 | 2018-07-27 | 上海健康医学院 | 一种动态可控的微剂量药液精准输送系统及方法 |
| KR20210031435A (ko) * | 2018-06-06 | 2021-03-19 | 미노릭스 테라퓨틱스 에스.엘. | 치료학적 유효량의 5-[[4-[2-[5-(1-히드록시에틸)피리딘-2-일]에톡시]페닐]메틸]-1,3-티아졸리딘-2,4-디온을 투여하는 방법 |
| ES3041713T3 (en) * | 2018-10-23 | 2025-11-13 | Amgen Inc | Automatic calibration and automatic maintenance of spectroscopic models for real-time predictions |
| CA3124675A1 (en) * | 2018-12-21 | 2020-06-25 | Thsee, Llc | Method for optimization of cannabis dosage and mixture of active cannabinoids |
| WO2021097653A1 (en) * | 2019-11-19 | 2021-05-27 | National University Of Singapore | Optimisation of combination drug therapies |
| US20210304846A1 (en) * | 2020-03-29 | 2021-09-30 | Stephen J. Brown | Personalized compounding of therapeutic components and tracking of their influence on a measured parameter using a complex interaction model |
| CN111489822A (zh) * | 2020-04-02 | 2020-08-04 | 首都医科大学附属北京安定医院 | 一种治疗药物监测结果解释系统 |
| CN111870770A (zh) * | 2020-08-31 | 2020-11-03 | 上海应用技术大学 | 一种智能远程输液泵控制监测系统 |
| KR102481888B1 (ko) | 2020-09-01 | 2022-12-28 | 고려대학교 산학협력단 | 딥러닝을 이용한 수면유도제 투여량 예측방법 및 예측 장치 |
| CN113823365A (zh) * | 2021-09-30 | 2021-12-21 | 北京兴德通医药科技股份有限公司 | 临床研究质量控制方法、系统、电子设备和存储介质 |
| KR102840320B1 (ko) * | 2023-02-13 | 2025-08-01 | 주식회사 지오비전 | 공동 다층 퍼셉트론 모델을 이용한 약제 농도 모니터링 시스템 |
| WO2025006459A1 (en) * | 2023-06-29 | 2025-01-02 | Prxcision, Inc. | Machine learning for real-time decision support |
| KR20250028730A (ko) * | 2023-08-22 | 2025-03-04 | 충북대학교 산학협력단 | 혈중 농도 변화 모사를 위한 약물 평가 방법 및 약물 평가 시스템 |
| WO2025059764A1 (en) * | 2023-09-18 | 2025-03-27 | Appmed Inc. | System and method for monitoring and identifying posology efficacy for an individual |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2372782A1 (en) * | 1999-05-11 | 2000-11-16 | Wing Cheung | Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| US7124031B1 (en) * | 2000-05-11 | 2006-10-17 | Medco Health Solutions, Inc. | System for monitoring regulation of pharmaceuticals from data structure of medical and labortory records |
| US6599281B1 (en) * | 2000-05-03 | 2003-07-29 | Aspect Medical Systems, Inc. | System and method for adaptive drug delivery |
| US7860583B2 (en) * | 2004-08-25 | 2010-12-28 | Carefusion 303, Inc. | System and method for dynamically adjusting patient therapy |
| US20040014097A1 (en) * | 2002-05-06 | 2004-01-22 | Mcglennen Ronald C. | Genetic test apparatus and method |
| US7585680B2 (en) * | 2003-08-28 | 2009-09-08 | Marshfield Medical Research And Education Foundation | Method and device for monitoring medication usage |
| GB0420256D0 (en) * | 2004-09-13 | 2004-10-13 | Cassells John M | Method and apparatus for sampling and analysis of fluids |
| CA2610294C (en) | 2005-05-09 | 2023-10-03 | Theranos, Inc. | Point-of-care fluidic systems and uses thereof |
| US20060283465A1 (en) * | 2005-06-16 | 2006-12-21 | Nickel Janice H | Smart drug delivery system and a method of implementation thereof |
| DK2508621T3 (en) * | 2005-11-29 | 2015-01-12 | Childrens Hosp Medical Center | Optimization and individualization of drug selection and dosage |
| KR100867324B1 (ko) * | 2007-03-13 | 2008-11-06 | 가톨릭대학교 산학협력단 | 혈중약물농도측정 처방 자동화 방법 |
| US20080262867A1 (en) * | 2007-04-18 | 2008-10-23 | Janus Health, Inc. | Patient management system and method |
| CN100580448C (zh) * | 2007-08-10 | 2010-01-13 | 复旦大学附属华山医院 | 一种测定人血浆中苯妥英及其前体药物和代谢物的方法 |
| CN103323610B (zh) | 2007-10-02 | 2016-12-28 | 赛拉诺斯股份有限公司 | 模块化现场护理装置及其应用 |
| US20110184379A1 (en) * | 2008-03-27 | 2011-07-28 | Medtronic, Inc. | Method and system to define patient specific therapeutic regimens by means of pharmacokinetic and pharmacodynamic tools |
| WO2010097796A1 (en) * | 2009-02-26 | 2010-09-02 | Mor Research Applications Ltd. | Method and system for automatic monitoring of diabetes related treatments |
| EP2457098B1 (en) * | 2009-07-22 | 2014-08-13 | Eli Lilly and Company | Method for predicting weight gain associated with a pharmaceutical therapy |
| US20120203573A1 (en) * | 2010-09-22 | 2012-08-09 | I.D. Therapeutics Llc | Methods, systems, and apparatus for optimizing effects of treatment with medication using medication compliance patterns |
-
2013
- 2013-10-21 US US14/059,173 patent/US20140114676A1/en not_active Abandoned
- 2013-10-22 AU AU2013334700A patent/AU2013334700A1/en not_active Abandoned
- 2013-10-22 HK HK16102367.3A patent/HK1214498A1/zh unknown
- 2013-10-22 CN CN201380067536.9A patent/CN104884029A/zh active Pending
- 2013-10-22 CA CA2887669A patent/CA2887669A1/en active Pending
- 2013-10-22 IN IN3826DEN2015 patent/IN2015DN03826A/en unknown
- 2013-10-22 KR KR1020157011292A patent/KR20150079660A/ko not_active Withdrawn
- 2013-10-22 EP EP13848501.6A patent/EP2911642B1/en active Active
- 2013-10-22 WO PCT/US2013/066238 patent/WO2014066428A1/en not_active Ceased
-
2016
- 2016-05-19 US US15/159,568 patent/US20160342768A1/en not_active Abandoned
-
2018
- 2018-06-08 AU AU2018204120A patent/AU2018204120A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN104884029A (zh) | 2015-09-02 |
| KR20150079660A (ko) | 2015-07-08 |
| CA2887669A1 (en) | 2014-05-01 |
| AU2018204120A1 (en) | 2018-06-28 |
| HK1214498A1 (zh) | 2016-07-29 |
| US20140114676A1 (en) | 2014-04-24 |
| US20160342768A1 (en) | 2016-11-24 |
| EP2911642B1 (en) | 2022-11-16 |
| AU2013334700A1 (en) | 2015-04-30 |
| EP2911642A4 (en) | 2016-06-08 |
| WO2014066428A1 (en) | 2014-05-01 |
| EP2911642A1 (en) | 2015-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN03826A (pm) | ||
| MX2021011813A (es) | Sistemas y metodos para compensar a largo plazo la sensibilidad de la deriva de sensores electroquimicos de gas expuestos a oxido nitrico. | |
| CY1124135T1 (el) | Δοσολογικα σχηματα για την αγωγη της νοσου ρομρε | |
| EP2911717A4 (en) | DEVICE, SYSTEM AND METHOD FOR TRACKING THE DELIVERY OF A MEDICAMENT | |
| SG10201902353UA (en) | Capturing specific nucleic acid materials from individual biological cells in a micro-fluidic device | |
| MX2023000359A (es) | Provision de un regimen de dosificacion de farmaco farmacocinetico. | |
| EP2884394A4 (en) | ADMINISTRATIVE SYSTEM AND ADMINISTRATIVE PROCEDURE | |
| WO2014179594A3 (en) | System and method for monitoring administration of nutrition | |
| EP2968732A4 (en) | LIQUID DISPENSING SYSTEM AND METHOD FOR LIQUID DISTRIBUTION TO A PATIENT | |
| WO2012040248A3 (en) | Automatic association of medical elements | |
| UA117103C2 (uk) | Сполука, яка має активність агоніста глюкагону | |
| MX2020001369A (es) | Sistema de analisis para el cuidado de un paciente. | |
| WO2013048558A3 (en) | Methods of therapeutic monitoring of nitrogen scavenging drugs | |
| MX2016008138A (es) | Sistema para el suministro transdermico de ingredientes activos. | |
| BR112014010139A2 (pt) | formulação farmacêutica, método de redução do nível de açúcar no sangue de um paciente e polipeptídeo | |
| FI20135152A7 (fi) | Farmaseuttinen yhdistelmäkoostumus ja menetelmiä diabeteksen ja metabolisten sairauksien hoidossa | |
| BR112013029199A2 (pt) | sistema de distribuição de fármacos, dispositivo de distribuição de dois fármacos, método para preparar o mesmo, comprimido para administração sublingual de um ingrediente ativo, e, método para a administração de um ingrediente ativo a um indivíduo | |
| MX373138B (es) | Inhalador de polvo seco y método de uso. | |
| EA201400737A1 (ru) | Система доставки на основе множества пеллет с немедленным высвобождением активного вещества | |
| PH12015502556A1 (en) | Modified release formulation | |
| NZ754328A (en) | Marker for acid sphingomyelinase disorders and uses thereof | |
| MX2015009891A (es) | Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion. | |
| ATE499040T1 (de) | Vorrichtung zur arzneimittelverabreichung und/oder überwachung des zustandes eines patienten | |
| EA201391023A1 (ru) | Способ снижения боли у животных семейства собачьих с помощью трансдермального раствора фентанила | |
| BR112017022984A2 (pt) | dispositivo para facilitar o posicionamento de um cateter para administrar um medicamento em um paciente que esteja respirando espontaneamente |